Clinical assortment of preeclampsia in women with diabetes mellitus type 1 during early pregnancy: an investigative analysis
DOI:
https://doi.org/10.51253/pafmj.v74iSUPPL-2.11175Keywords:
Early Pregnancy, Type-1 Diabetes mellitus, Preeclampsia, Vasculopathy.Abstract
Objective: To determine the clinical predictors of preeclampsia in T1DM women during first trimester.
Study Design: Cross-sectional study
Place and Duration of Study: Gynaecology and Obstetrics Department of Pakistan Emirates Military Hospital, Rawalpindi, Pakistan, from Dec 2022 to Oct 2023.
Methodology: A cross sectional study of 245 T1DM women was conducted in this group. Two categories of women were identified: normal (n=221) and PE (n=24). Clinical data were gathered in the first trimester, and the eGDR, (mg/kg/min) was used to quantify insulin resistance (IR) in the first trimester. Statistical analysis was done to look for variables linked to PE.
Results: Preeclampsia was diagnosed in primiparae. The greatest predictor of PE was vasculopathy (OR 28.15 95% CI 8.0-98.6, p=<0.0001), followed by the duration of diabetes (25 years). PE was linked to a higher gestational weight gain (GWG) of 14 kg. Blood pressure factors of PE included both diastolic and systolic readings. PE and glycated haemoglobin (HbA1c) levels (7.5; 6.2–8.6) were substantially correlated. eGDR and PE had a negative correlation (8.6(6.6–10.6)). Triglycerides (TG) (0.94(0.6– 1.2)) were the lipids that showed a positive correlation with PE, and this correlation was true regardless of HbA1c levels.
Conclusion: In T1DM women, primiparity and vasculopathy were the most significant risk factors for PE. Higher GWG was also linked to PE. PE was linked to increased TG and HbA1c levels. More research is necessary to determine the relationship between IR and PE.
Downloads
References
Gutaj P, Zawiejska A, Mantaj U, Wender-Ożegowska E. Determinants of preeclampsia in women with type 1 diabetes. Acta Diabetologica 2017; 54: 1115-1121.
https://doi.org/10.1007/s00592-017-1053-3
Amor AJ, Vinagre I, Valverde M, Pané A, Urquizu X, Meler E, et al. Preeclampsia is associated with increased preclinical carotid atherosclerosis in women with type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism 2020; 105(1): 85-95.
https://doi.org/10.1210/clinem/dgz031
Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Current diabetes reports. 2015 Mar; 15: 1-0.
https://doi.org/10.1007/s11892-015-0579-4
Vestgaard M, Sommer MC, Ringholm L, Damm P, Mathiesen ER. Prediction of preeclampsia in type 1 diabetes in early pregnancy by clinical predictors: a systematic review. The Journal of Maternal-Fetal & Neonatal Medicine 2018 Jul 18; 31(14): 1933-9.
https://doi.org/10.1080/14767058.2017.1331429
Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, et al. Subclinical first trimester renal abnormalities are associated with preeclampsia in normoalbuminuric women with type 1 diabetes. Diabetes Care 2018; 41(1): 120-127.
https://doi.org/10.2337/dc17-1635
MedCalc software
https://www.medcalc.org/calc/odds_ratio.php
Cavero-Redondo I, Martínez-Vizcaíno V, Soriano-Cano A, Martínez-Hortelano JA, Sanabria-Martínez G, Álvarez-Bueno C. Glycated haemoglobin A1c as a predictor of preeclampsia in type 1 diabetic pregnant women: a systematic review and meta-analysis. Pregnancy Hypertension 2018; 14: 49-54.
https://doi.org/10.1016/j.preghy.2018.04.004
Wotherspoon AC, Young IS, McCance DR, Holmes VA. Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review. Journal of diabetes and its complications. 2016; 30(5): 958-966.
https://doi.org/10.1016/j.jdiacomp.2016.02.001
Persson M, Cnattingius S, Wikström AK, Johansson S. Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes. Diabetologia 2016; 59: 2099-105.
https://doi.org/10.1007/s00125-016-4035-z
Ottanelli S, Napoli A, Festa C, Clemenza S, Mecacci F. Hypertension and preeclampsia in pregnancy complicated by diabetes. InGestational Diabetes 2020 (Vol. 28, pp. 171-182). Karger Publishers.
https://doi.org/10.1159/000480173
Nørgaard SK, Vestgaard MJ, Jørgensen IL, Ásbjörnsdóttir B, Ringholm L, McIntyre HD, Damm P, Mathiesen ER. Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes. Diabetes Research and Clinical Practice 2018; 138: 229-237.
https://doi.org/10.1016/j.diabres.2018.02.014
Oppermann ML, Alessi J, Hirakata VN, Wiegand DM, Reichelt AJ. Preeclampsia in women with pregestational diabetes–a cohort study. Hypertension in Pregnancy 2020; 39(1): 48-55.
https://doi.org/10.1080/10641955.2019.1704002
Waernbaum I, Dahlquist G, Lind T. Perinatal risk factors for type 1 diabetes revisited: a population-based register study. Diabetologia 2019; 62: 1173-84.
https://doi.org/10.1007/s00125-019-4874-5
Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and current clinical management of preeclampsia. Current hypertension reports. 2017; 19: 1-6.
https://doi.org/10.1007/s11906-017-0757-7
Mathiesen ER. Pregnancy outcomes in women with diabetes—lessons learned from clinical research: the 2015 Norbert Freinkel award lecture. Diabetes Care. 2016; 39(12): 2111-7.
https://doi.org/10.2337/dc16-1647
Temple RC, Aldridge V, Stanley K, Murphy HR. Glycaemic control throughout pregnancy and risk of pre‐eclampsia in women with type I diabetes. BJOG: An International Journal of Obstetrics & Gynaecology 2006; 113(11): 1329-32.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Arfa Khalid, Bilqees Akhter, Tehreem Yazdani, Sadaf Zohra, Shazia Firdos Chohan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
